Unichem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,604	2,895	895.8	1,548	1,838	1,092
Short-Term Investments	-	-	-	-	-	2,260
Trading Asset Securities	-	-	-	13.4	15.36	376.28
Cash & Short-Term Investments	1,604	2,895	895.8	1,561	1,853	3,728
Cash Growth	-17.11%	223.15%	-42.61%	-15.76%	-50.30%	18.76%
Accounts Receivable	9,858	8,286	7,788	6,423	5,886	4,954
Other Receivables	-	52.9	156	172.3	96.35	135.5
Receivables	9,859	8,339	7,945	6,596	5,983	5,090
Inventory	10,835	9,810	9,932	7,443	6,288	6,083
Prepaid Expenses	-	238.6	221.2	211.3	234.32	210.48
Other Current Assets	1,357	723.5	1,386	1,656	1,561	1,372
Total Current Assets	23,654	22,006	20,380	17,467	15,919	16,484
Property, Plant & Equipment	12,891	13,038	13,100	13,172	14,026	14,823
Long-Term Investments	0.2	0.2	0.2	0.2	1.61	2.85
Goodwill	15.5	15.5	15.5	15.5	15.45	15.45
Other Intangible Assets	52.8	73.3	187	563.6	-	-
Long-Term Deferred Tax Assets	329	305.6	257.8	67.8	101.13	43.55
Other Long-Term Assets	2,132	1,934	1,753	1,462	1,867	1,818
Total Assets	39,076	37,374	35,694	32,750	31,930	33,188

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	4,537	3,566	3,869	3,513	2,907	1,832
Accrued Expenses	-	538.4	1,905	1,825	699.37	555.94
Short-Term Debt	-	4,154	3,403	1,553	2,081	2,157
Current Portion of Long-Term Debt	4,422	142.2	288.7	256.6	256.63	256.63
Current Portion of Leases	54.9	53.7	46.1	42.1	51.6	42.18
Current Income Taxes Payable	1.8	-	43.4	22.1	4.91	20.95
Current Unearned Revenue	-	-	9.7	76.9	245.27	269.49
Other Current Liabilities	990.7	404.4	378.1	88.3	150.56	387.32
Total Current Liabilities	10,007	8,859	9,943	7,376	6,396	5,521
Long-Term Debt	323.5	391.2	608.1	382.2	636.49	890.11
Long-Term Leases	182.1	260	251.9	241.6	114.93	145.71
Pension & Post-Retirement Benefits	-	66.8	115.1	86.2	135.07	128.81
Long-Term Deferred Tax Liabilities	529.8	398.8	-	-	-	-
Other Long-Term Liabilities	219.1	223.8	269.9	280.5	294.95	317.72
Total Liabilities	11,261	10,200	11,188	8,367	7,577	7,004

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	140.8	140.8	140.8	140.8	140.81	140.81
Additional Paid-In Capital	-	13.3	13.3	13.3	13.3	13.3
Retained Earnings	-	27,076	24,562	23,640	23,975	25,061
Comprehensive Income & Other	27,674	-56.1	-210	588.5	223.87	969.19
Shareholders' Equity	27,814	27,174	24,506	24,383	24,353	26,184
Total Liabilities & Equity	39,076	37,374	35,694	32,750	31,930	33,188

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	4,983	5,002	4,598	2,475	3,140	3,492
Net Cash (Debt)	-3,379	-2,107	-3,702	-914.3	-1,288	236.25
Net Cash Growth	-	-	-	-	-	-87.87%
Net Cash Per Share	-47.83	-29.87	-52.42	-12.99	-18.29	3.35
Filing Date Shares Outstanding	70.32	70.41	70.41	70.41	70.41	70.41
Total Common Shares Outstanding	70.32	70.41	70.41	70.41	70.41	70.41
Working Capital	13,647	13,147	10,436	10,091	9,523	10,963
Book Value Per Share	395.56	385.97	348.07	346.32	345.90	371.90
Tangible Book Value	27,746	27,086	24,303	23,804	24,338	26,169
Tangible Book Value Per Share	394.59	384.71	345.19	338.10	345.68	371.68
Land	-	37.5	37.5	37.8	37.8	37.8
Buildings	-	5,397	5,499	5,108	5,101	3,872
Machinery	-	13,445	13,362	11,908	11,587	9,123
Construction In Progress	-	1,001	306.7	1,227	1,475	4,938